Skip to main content
Top

2013 | OriginalPaper | Hoofdstuk

13. Stamceltransplantatie

Auteurs : dr. L.F. Verdonck, dr. C. Huisman

Gepubliceerd in: Hematologie

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Inleiding

Hematopoëtische stamceltransplantatie (HSCT) wordt voor twee doeleinden uitgevoerd:
  • om zieke of afwezige hematopoëtische cellen te vervangen door gezonde;
  • om een hogere dosis chemo- en/of radiotherapie (hoger dan een ‘conventionele’ dosis) te kunnen geven.
Literatuur
go back to reference Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336:897-950.PubMedCrossRef Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone marrow transplantation. N Engl J Med. 1997;336:897-950.PubMedCrossRef
go back to reference Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Bone Marrow Transplant. 2005;11:945-56.CrossRef Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Bone Marrow Transplant. 2005;11:945-56.CrossRef
go back to reference Huisman C, Visser O, Verdonck LF. Late complicaties na allogene stamceltransplantaties bij volwassenen. Ned Tijdschr Hematol. 2010;7:188-97. Huisman C, Visser O, Verdonck LF. Late complicaties na allogene stamceltransplantaties bij volwassenen. Ned Tijdschr Hematol. 2010;7:188-97.
go back to reference Kolb HJ, Schmid C, Barrett AJ, Schendel DJ. Graft-versus-leukemia in allogeneic chimeras. Blood. 2004;103:767-76.PubMedCrossRef Kolb HJ, Schmid C, Barrett AJ, Schendel DJ. Graft-versus-leukemia in allogeneic chimeras. Blood. 2004;103:767-76.PubMedCrossRef
go back to reference Majhail NS, Rizzo JD, Lee SJ, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant. 2012;47:337-41.PubMedCrossRef Majhail NS, Rizzo JD, Lee SJ, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant. 2012;47:337-41.PubMedCrossRef
go back to reference Niederwieser D, Maris M, Shizuru JA, et al. Low-dose total body-irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood. 2003;101:1620-9.PubMedCrossRef Niederwieser D, Maris M, Shizuru JA, et al. Low-dose total body-irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood. 2003;101:1620-9.PubMedCrossRef
go back to reference Passweg JR, Baldomero H, Gratwohl A, et al. The EBMT activity survey: 1990-2010. Bone Marrow Transplant. 2012;47:906-23.PubMedCrossRef Passweg JR, Baldomero H, Gratwohl A, et al. The EBMT activity survey: 1990-2010. Bone Marrow Transplant. 2012;47:906-23.PubMedCrossRef
Metagegevens
Titel
Stamceltransplantatie
Auteurs
dr. L.F. Verdonck
dr. C. Huisman
Copyright
2013
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-9906-2_13